NCT04722952 2021-12-03PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AMLThe First Affiliated Hospital of Soochow UniversityPhase 3 Unknown30 enrolled